Relmada Therapeutics RLMD
NASDAQ RLMD
$3.28 +0.07 (+2.02%)
As of: Oct 22, 2026 · 11:39 AM EDT

Relmada Therapeutics (RLMD) Ending Cash Balance (2014 - 2026)

Updated

Analysis

Relmada Therapeutics (RLMD) Ending Cash Balance (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,175.59 Bn 1,144.18 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 639.41 Bn 557.93 Bn 17.26 Bn 20.42 Bn
3 AbbVie 502.56 Bn 475.67 Bn 12.70 Bn 6.57 Bn
4 Merck 375.27 Bn 329.65 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 303.16 Bn 267.15 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 268.63 Bn 242.32 Bn 12.86 Bn 4.88 Bn
7 Amgen 242.12 Bn 197.52 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.40 Bn 167.60 Bn 6.22 Bn 3.18 Bn
9 Pfizer 172.79 Bn 119.44 Bn 10.94 Bn 1.03 Bn
10 Relmada Therapeutics 368.59 Mn -189.99 Mn - 11.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.33 Mn
Mar 31, 2026 9.78 Mn
Dec 31, 2025 3.50 Mn
Sep 30, 2025 1.38 Mn
Jun 30, 2025 1.35 Mn
Mar 31, 2025 1.15 Mn
Dec 31, 2024 3.86 Mn
Sep 30, 2024 1.48 Mn
Jun 30, 2024 2.09 Mn
Mar 31, 2024 1.34 Mn
Dec 31, 2023 4.09 Mn
Sep 30, 2023 6.70 Mn
Jun 30, 2023 14.47 Mn
Mar 31, 2023 28.89 Mn
Dec 31, 2022 5.40 Mn
Sep 30, 2022 42.52 Mn
Jun 30, 2022 37.26 Mn
Mar 31, 2022 44.93 Mn
Dec 31, 2021 44.44 Mn
Sep 30, 2021 11.45 Mn
API Access

Relmada Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=RLMD&period=max&api_key=YOUR_API_KEY